A vast and virgin structural space, protected with a double-layer IP.
Analogous and novel lipid tails of increased complexity are available within weeks from in-silico design.
Fast and inexpensive access to predefined and/or proprietary lipids.
No special reaction conditions are required, and SilBoRed™ has been proven to be an easy-to-handle reduction technology.
Standard lipids are available, cleaner and less expensive than via the currently available synthesis.
A unique solution to one of the most pressing bottlenecks of the pharma industry – delivery of therapeutic oligonucleotides.
Using off-the-shelf and stable building blocks.
Billions of novel lipids designed from building blocks accessible only using the SilBoRed™ reduction technology.
A vast and virgin structural space, protected with a double-layer IP.
A unique solution for one of the most pressing bottlenecks of the pharma industry – delivery of RNA drugs and vaccines.
Fast and inexpensive access to predefined and/or proprietary lipids.
No special reaction condition are required and SilBoRed has been proven to be easy-to-handle reduction technology.
Analogous and novel lipid tails of increased complexity, within weeks from the in-silico design.
Analogous and novel lipid tails of increased complexity, within weeks from the in-silico design.
Using off-the-shelf stable building blocks.
Billions of novel lipids to be designed from building blocks inaccessible to the standard chemical toolbox (Secondary IP).